$NKTR NEKTAR THERAPEUTICS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEKTAR THERAPEUTICS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEKTAR THERAPEUTICS. Insider overview, share value development, latest insider transactions and email notifications about new events in NEKTAR THERAPEUTICS for free.
IRS Number: 943134940
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: NKTR
Company Address: 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO 94158
Phone number: (415) 482-5300
Former name: INHALE THERAPEUTIC SYSTEMS, date of change: 1994-03-03
Former name: INHALE THERAPEUTIC SYSTEMS INC, date of change: 1998-07-23
Market Capitalization: $2.01B
Prev close: $13.17
Average Daily Volume: 1,308,190
Days Low: $12.71
Year Low: $10.52
Year High: $19.98
NEKTAR THERAPEUTICS Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 19 2021 | NKTR | NEKTAR THERAPEUTIC ... | Wilson Mark Andrew | SVP & General Couns ... | Sell | S | 18.30 | 1,917 | 35,081 | 74,810 | 76.7 K to 74.8 K (-2.50 %) |
| May 19 2021 | NKTR | NEKTAR THERAPEUTIC ... | NORTHCOTT JOHN | SVP & Chief Commerc ... | Sell | S | 18.30 | 6,085 | 111,356 | 207,107 | 213.2 K to 207.1 K (-2.85 %) |
| May 14 2021 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | M | 13.80 | 8,000 | 110,400 | 24,000 | |
| May 14 2021 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Sell | S | 19.34 | 8,000 | 154,720 | 280,573 | 288.6 K to 280.6 K (-2.77 %) |
| May 14 2021 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Buy | M | 13.80 | 8,000 | 110,400 | 288,573 | 280.6 K to 288.6 K (+2.85 %) |
| Apr 16 2021 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | M | 13.80 | 8,000 | 110,400 | 32,000 | |
| Apr 16 2021 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Sell | S | 18.98 | 8,000 | 151,840 | 280,573 | 288.6 K to 280.6 K (-2.77 %) |
| Apr 16 2021 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Buy | M | 13.80 | 8,000 | 110,400 | 288,573 | 280.6 K to 288.6 K (+2.85 %) |
| Feb 18 2021 | NKTR | NEKTAR THERAPEUTIC ... | Zalevsky Jonathan | Chief R&D Officer | Sell | S | 22.37 | 24,141 | 540,034 | 266,176 | 290.3 K to 266.2 K (-8.32 %) |
| Feb 18 2021 | NKTR | NEKTAR THERAPEUTIC ... | Wilson Mark Andrew | SVP & General Couns ... | Sell | S | 22.37 | 2,173 | 48,610 | 76,727 | 78.9 K to 76.7 K (-2.75 %) |
| Feb 18 2021 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 22.37 | 11,705 | 261,841 | 164,552 | 176.3 K to 164.6 K (-6.64 %) |
| Feb 18 2021 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 22.37 | 11,495 | 257,143 | 447,198 | 458.7 K to 447.2 K (-2.51 %) |
| Feb 18 2021 | NKTR | NEKTAR THERAPEUTIC ... | NORTHCOTT JOHN | SVP & Chief Commerc ... | Sell | S | 22.37 | 15,358 | 343,558 | 213,192 | 228.6 K to 213.2 K (-6.72 %) |
| Feb 18 2021 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Sell | S | 22.37 | 7,977 | 178,445 | 258,996 | 267 K to 259 K (-2.99 %) |
| Feb 04 2021 | NKTR | NEKTAR THERAPEUTIC ... | Wilson Mark Andrew | SVP & General Couns ... | Option Exercise | M | 8.80 | 5,344 | 47,027 | 0 |